Objects
Brochet, Bruno, Hupperts, Raymond, Langdon, Dawn, Solari, Alessandra, Piehl, Fredrik, Lechner-Scott, Jeannette, Montalban, Xavier, Selmaj, Krzysztof, Valis, Martin, Rejdak, Konrad, Havrdova, Eva K., Patti, Francesco, Alexandri, Nektaria, Nolting, Axel, Keller, Birgit. Elsevier; 2022. Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis.
Brochet, Bruno, Solari, Alessandra, Alexandri, Nektaria, Smyk, Andrzej, Nolting, Axel, Keller, Birgit, Montalban, Xavier, Kubala Havrdova, Eva, Lechner-Scott, Jeannette, Piehl, Fredrik, Langdon, Dawn, Hupperts, Raymond, Selmaj, Krzysztof, Patti, Francesco, Brieva, Luis, Maida, Eva Maria. Sage; 2023. Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study.